Motif Neurotech
@motifneuro
Fighting silence with science. Building Therapeutic BCI in Houston, TX. www.motifneuro.tech
Our first site in Iowa City is now recruiting patients for our RESONATE study! Visit registry.motifneuro.tech to learn more and see if you're eligible for our treatment-resistant depression study. #mentalhealth #BCI #neurotech
🚀 Our RESONATE study is now active and enrolling at its first site! 🚀 Our University of Iowa site is open to research participants, lead by Nicholas Trapp, MD. If you live near one of these sites and want to check your eligibility, please sign up on our patient registry ➡️ registry.motifneuro.tech
Jacob Robinson presented at the Neuromodec 2026 NYC Neuromodulation Conference at @ccnyresearch.bsky.social this past weekend about the therapeutic possibilities of bidirectional (stimulation + recording) brain computer interfaces.
🥳 Please help us welcome, Odell Roberts Jr as our Director of Quality 🥳 Odell brings more than 30 years of experience in medtech, with leadership roles spanning quality, regulatory, and operations. Welcome Odell!
We're excited to welcome Amanda Geisinger as our Director of Lived Experience!! Amanda is an Emmy-winning product & user experience design director, a survivor of long term severe mental illness, a voice for those who still suffer and an enthusiastic cheerleader for advancements in brain healing.
Today, we launched our patient registry and are accepting submissions from individuals with treatment-resistant depression (TRD) who may be interested in learning about potential future research opportunities. Sign up here 👉 registry.motifneuro.tech
Big thank you to Advanced Research Projects Agency for Health (ARPA-H) for visiting Motif HQ. ARPA-H supports transformative research to drive biomedical and health breakthroughs ranging from molecular to societal to provide transformative health solutions for all.
Do you think the next moonshot is in mental health? We do. 🌝 Thanks to Astro Teller of X, the Moonshot Factory, for visiting @jacobrobinson.bsky.social lab at @riceneuro.bsky.social
Motif Neurotech CEO and Co-Founder @jacobrobinson.bsky.social will be speaking at the 2025 New York Brain-Computer Interface Symposium (NYBCI). Register at nybci.com Moderated by @bloomberg.com @ikeswetlitz.bsky.social
We always love @onemindorg.bsky.social Music Festival!! We're grateful to be a part of this mission-aligned community! #Music4BrainHealth @jacobrobinson.bsky.social
Yesterday, we spent the day on Capitol Hill 🇺🇸 for the Rally for Medical Research. Jon Nelson joined our friends from @onemindorg.bsky.social to march and meet in support of making medical research a national priority.
Today is World Suicide Prevention. Motif stands with our community today to shine a light on suicide and because the silence and stigma in our society only increases the danger of this disease💡. Let's change the narrative so we can get well and stay well, together 🫂.
🇬🇧 Welcome and congrats to our first international employee, Sudam Dias! 🇬🇧 Based in London, Sudam will work closely with our partners at MintNeuro as we advance neural ASIC development through our collaboration with Advanced Research + Invention Agency (ARIA).
We’re thrilled to welcome Andrew Chen, MD, PhD to our team as a Senior Scientist! Andrew is a psychiatrist and will specialize in machine learning at Motif. He'll also work closely with our Community Advisory Board to integrate our lived experience experts into clinical efforts.
@jacobrobinson.bsky.social explores the history and future of regulating our biology with technology on the MARS stage.
It’s a long road for someone suffering from severe mental illness. Antidepressants, TMS sessions at a clinic, ketamine, ECT. A plethora of antiquated options that leave patients still searching for relief. “How is this real?”
Last month, we had the privilege of being invited to share our advancements and our vision for the future of mental health care at the MARS conference.
Check out the view from Deep Tech Week NYC this week 🏙️ 😮💨. @jacobrobinson.bsky.social shared the stage with some great neurotech leaders for an evening of networking and industry collaboration. Shoutout to Psymed, Data Joint and Actual VC for hosting such a wonderful night!
Please join us in congratulating Julie Goode on her promotion to Vice President of Clinical Affairs! Julie will continue to lead our clinical research efforts as we prepare for clinical trials in 2025! 🚀
We're thrilled to welcome Joshua Woods, PhD as our Senior Electrical Engineer! Josh has already been integral in our work for years. His doctoral work at @jacobrobinson.bsky.social @riceuniversity.bsky.social included pioneering the first DOT and magnetoelectric power for neural networks.
We brought the whole team to Houston this week for our 2025 Strategy Summit. The team synergy is palpable and we're so excited for everything ahead of us this year 🧠 🛫
We're honored to be selected by @aria-research.bsky.social for a multimillion-dollar award through their Precision Neurotechnologies Program. This funding will accelerate the development of our therapeutic Brain-Computer Interface to treat mood, attention, and sleep disorders 🧠🚀
Our Team got their groove on at the roller rink for the annual Motif holiday party! Wishing our team, advisors, investors, vendors, supporters and our industry a happy holiday season. Take extra care of yourselves and your loved ones these next few weeks.